Misplaced Pages

Latest revision as of 06:23, 16 May 2024

Percutaneous vertebroplasty
Typical interventional suite setup for kyphoplasty
ICD-9-CM	81.65
MedlinePlus	007512
[edit on Wikidata]

Vertebral augmentation, including vertebroplasty and kyphoplasty, refers to similar percutaneous spinal procedures in which bone cement is injected through a small hole in the skin into a fractured vertebra in order to relieve back pain caused by a vertebral compression fracture. After decades of medical research into the efficacy and safety of vertebral augmentation, there is still a lack of consensus regarding certain aspects of vertebroplasty and kyphoplasty.

Procedure

Vertebroplasty and kyphoplasty are the two most common procedures for spinal augmentation. These medical terms are classical compounds of the suffix -plasty meaning "molding or shaping surgically" (from Ancient Greek plastós "molded, formed") and the prefixes vertebro- "vertebra" (from Latin vertebra "joint, joint of the spine") and kypho- "humped; stooping forward" (from Ancient Greek kyphos "crooked").

Vertebroplasty

Vertebroplasty is typically performed by a spine surgeon or interventional radiologist. It is a minimally invasive procedure and patients usually go home the same or next day as the procedure. Patients are given local anesthesia and light sedation for the procedure, though it can be performed using only local anesthetic for patients with medical problems who cannot tolerate sedatives well.

During the procedure, bone cement is injected with a biopsy needle into the collapsed or fractured vertebra. The needle is placed with fluoroscopic x-ray guidance. The cement (most commonly poly methyl methacrylate (PMMA), although more modern cements are used as well) quickly hardens and forms a support structure within the vertebra that provide stabilization and strength. The needle makes a small puncture in the patient's skin that is easily covered with a small bandage after the procedure.

Kyphoplasty

Kyphoplasty is a variation of a vertebroplasty which attempts to restore the height and angle of kyphosis of a fractured vertebra (of certain types), followed by its stabilization using injected bone cement. The procedure typically includes the use of a small balloon that is inflated in the vertebral body to create a void within the cancellous bone prior to cement delivery. Once the void is created, the procedure continues in a similar manner as a vertebroplasty, but the bone cement is typically delivered directly into the newly created void.

In a 2011 review Medicare contractor NAS determined that there is no difference between vertebroplasty and kyphoplasty, stating, "No clear evidence demonstrates that one procedure is different from another in terms of short- or long-term efficacy, complications, mortality or any other parameter useful for differentiating coverage."

Effectiveness

As of 2019, the effectiveness of vertebroplasty is not supported. A 2018 Cochrane review found no role for vertebroplasty for the treatment of acute or sub-acute osteoporotic vertebral fractures. The subjects in these trials had primarily non-acute fractures and prior to the release of the results they were considered the most ideal people to receive the procedure. After trial results were released vertebroplasty advocates pointed out that people with acute vertebral fractures were not investigated. A number of non-blinded trials suggested effectiveness, but the lack of blinding limits what can be concluded from the results and some have been criticized because of being funded by the manufacturer. One analysis has attributed the difference to selection bias.

Some have suggested that this procedure only be done in those with fractures less than 8 weeks old; however, analysis of the two blinded trials appear not to support the procedure even in this acute subgroup. Others consider the procedure only appropriate for those with other health problems making rest possibly detrimental, those with metastatic cancer as the cause of the spine fracture, or those who do not improve with conservative management.

Evidence does not support a benefit of kyphoplasty over vertebroplasty with respect to pain, but the procedures may differ in restoring lost vertebral height, and in safety issues like cement extravasation (leakage). As with vertebroplasty, several unblinded studies have suggested a benefit from balloon kyphoplasty. As of 2012, no blinded studies have been performed, and since the procedure is a derivative of vertebroplasty, the unsuccessful results of these blinded studies have cast doubt upon the benefit of kyphoplasty generally.

Some vertebroplasty practitioners and some health care professional organizations continue to advocate for the procedure. In 2010, the board of directors of the American Academy of Orthopaedic Surgeons released a statement recommending strongly against use of vertebroplasty for osteoporotic spinal compression fractures, while the Australian Medical Services Advisory Committee considers both vertebroplasty and kyphoplasty only to be appropriate in those who have failed to improve after a trial of conservative treatment, with conservative treatment (analgesics primarily) being effective in two-thirds of people. The National Institute for Health and Care Excellence similarly states that the procedure in those with osteoporotic fractures is only recommended as an option if there is severe ongoing pain from a recent fracture even with optimal pain management.

Vertebral body stenting, also known by the brand Kiva, is a similar procedure which also has poor evidence to support its use.

Adverse effects

Some of the associated risks are from the leak of acrylic cement to outside of the vertebral body. Although severe complications are extremely rare, infection, bleeding, numbness, tingling, headache, and paralysis may ensue because of misplacement of the needle or cement. This particular risk is decreased by the use of X-ray or other radiological imaging to ensure proper placement of the cement. In those who have fractures due to cancer, the risk of serious adverse events appears to be greater at 2%.

The risk of new fractures following these procedures does not appear to be changed; however, evidence is limited, and an increase risk as of 2012 is not ruled out. Pulmonary cement embolism is reported to occur in approximately 2-26% of procedures. It may occur with or without symptoms. Typically, if there are no symptoms, there are no long term issues. Symptoms do occur in about 1 in 2000 procedures. Other adverse effects include spinal cord injury in 0.6 per 1000.

Prevalence

In the United States in 2003 approximately 25,000 vertebroplasty procedures were paid for by Medicare. As of 2011/2012 this number may be as high as 70,000-100,000 per year.

History

Vertebroplasty had been performed as an open procedure for many decades to secure pedicle screws and fill tumorous voids. However, the results were not always worth the risk involved with an open procedure, which was the reason for the development of percutaneous vertebroplasty.

The first percutaneous vertebroplasty was performed in 1984 at the University Hospital of Amiens, France to fill a vertebral void left after the removal of a benign spinal tumor. A report of this and 6 other patients was published in 1987 and it was introduced in the United States in the early 1990s. Initially, the treatment was used primarily for tumors in Europe and vertebral compression fractures in the United States, although the distinction has largely gone away since then.

Society and culture

Cost

The cost of vertebroplasty in Europe as of 2010 was ~2,500 Euro. As of 2010 in the United States, when done as an outpatient, vertebroplasty costs around US$3300 while kyphoplasty costs around US$8100 and when done as an inpatient vertebroplasty cost ~US$11,000 and kyphoplasty US$16,000. The cost difference is due to kyphoplasty being an in-patient procedure while vertebroplasty is outpatient, and due to the balloons used in the kyphoplasty procedure. Medicare in 2011 spent about US$1 billion on the procedures. A 2013 study found that "the average adjusted costs for vertebroplasty patients within the first quarter and the first 2 years postsurgery were $14,585 and $44,496, respectively. The corresponding average adjusted costs for kyphoplasty patients were $15,117 and $41,339. There were no significant differences in adjusted costs in the first 9 months postsurgery, but kyphoplasty patients were associated with significantly lower adjusted treatment costs by 6.8–7.9% in the remaining periods through two years postsurgery."

Medicare response

In response to the NEJM articles and a medical record review showing misuse of vertebroplasty and kyphoplasty, US Medicare contractor Noridian Administrative Services (NAS) conducted a literature review and formed a policy regarding reimbursement of the procedures. NAS states that in order to be reimbursable, a procedure must meet certain criteria, including, 1) a detailed and extensively documented medical record showing pain caused by a fracture, 2) radiographic confirmation of a fracture, 3) that other treatment plans were attempted for a reasonable amount of time, 4) that the procedure is not performed in the emergency department, and 5) that at least one year of follow-up is planned for, among others. The policy, as referenced, applies only to the region covered by Noridian and not all of Medicare's coverage area. The reimbursement policy became effective on 20 June 2011. A 2015 comparative study of Medicare patients with vertebral compression fractures found that those who received balloon kyphoplasty and vertebroplasty therapies experienced lower mortality and overall morbidity than those who received conservative nonoperative management.

Promotion

In 2015, it was reported by The Atlantic that a person associated with a medical device company that sells equipment related to the kyphoplasty procedure had edited the Misplaced Pages article on the subject to promote claims about its efficacy. Assertions about the positive effects of kyphoplasty have been found to be unsupported or disproven, according to independent researchers.

References

1. Oxford English Dictionary 2009.
2. ^ Nicole Berardoni M.D, Paul Lynch M.D, and Tory McJunkin M.D. "Vertebroplasty and Kyphoplasty" 2008. Accessed 7 Aug 2009. http://www.arizonapain.com/Vertebroplasty-W.html
3. Wardlaw, Douglas; Van Meirhaeghe, Jan (2012), "Balloon kyphoplasty in patients with osteoporotic vertebral compression fractures", Expert Review of Medical Devices, 9 (4): 423–436, doi:10.1586/erd.12.27, PMID 22905846, S2CID 6448288
4. ^ Noridian Administrative Services, LLC. "Local Coverage Determination (LCD) for Vertebroplasty, Vertebral Augmentation; Percutaneous (L24383)". Centers for Medicare and Medicaid Services. United States Department of Health and Human Services. Retrieved 18 October 2011.
5. Buchbinder, R; Johnston, RV; Rischin, KJ; Homik, J; Jones, CA; Golmohammadi, K; Kallmes, DF (6 November 2018). "Percutaneous vertebroplasty for osteoporotic vertebral compression fracture". The Cochrane Database of Systematic Reviews. 2018 (11): CD006349. doi:10.1002/14651858.CD006349.pub4. PMC 6517304. PMID 30399208.
6. ^ Ebeling, Peter R; Akesson, Kristina; Bauer, Douglas C; Buchbinder, Rachelle; Eastell, Richard; Fink, Howard A; Giangregorio, Lora; Guanabens, Nuria; Kado, Deborah; Kallmes, David; Katzman, Wendy; Rodriguez, Alexander; Wermers, Robert; Wilson, H Alexander; Bouxsein, Mary L (January 2019). "The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force Report". Journal of Bone and Mineral Research. 34 (1): 3–21. doi:10.1002/jbmr.3653. PMID 30677181.
7. Buchbinder, Rachelle; Johnston, Renea V.; Rischin, Kobi J.; Homik, Joanne; Jones, C. Allyson; Golmohammadi, Kamran; Kallmes, David F. (6 November 2018). "Percutaneous vertebroplasty for osteoporotic vertebral compression fracture". The Cochrane Database of Systematic Reviews. 2018 (11): CD006349. doi:10.1002/14651858.CD006349.pub4. ISSN 1469-493X. PMC 6517304. PMID 30399208.
8. ^ Robinson, Y; Olerud, C (May 2012). "Vertebroplasty and kyphoplasty--a systematic review of cement augmentation techniques for osteoporotic vertebral compression fractures compared to standard medical therapy". Maturitas. 72 (1): 42–9. doi:10.1016/j.maturitas.2012.02.010. PMID 22425141.
9. Gangi, A; Clark, WA (August 2010). "Have recent vertebroplasty trials changed the indications for vertebroplasty?". CardioVascular and Interventional Radiology. 33 (4): 677–80. doi:10.1007/s00270-010-9901-3. PMID 20523998. S2CID 25901532.
10. Wardlaw, Douglas; Cummings, Steven (2009), "Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial", Lancet, 373 (9668): 1016–24, doi:10.1016/S0140-6736(09)60010-6, PMID 19246088, S2CID 12241054
11. McCullough, BJ; Comstock, BA; Deyo, RA; Kreuter, W; Jarvik, JG (Sep 9, 2013). "Major Medical Outcomes With Spinal Augmentation vs Conservative Therapy". JAMA Internal Medicine. 173 (16): 1514–21. doi:10.1001/jamainternmed.2013.8725. PMC 4023124. PMID 23836009.
12. Clark, WA; Diamond, TH; McNeil, HP; Gonski, PN; Schlaphoff, GP; Rouse, JC (2010-03-15). "Vertebroplasty for painful acute osteoporotic vertebral fractures: recent Medical Journal of Australia editorial is not relevant to the patient group that we treat with vertebroplasty". The Medical Journal of Australia. 192 (6): 334–7. doi:10.5694/j.1326-5377.2010.tb03533.x. PMID 20230351. S2CID 12672714.
13. Staples, MP; Kallmes, DF; Comstock, BA; Jarvik, JG; Osborne, RH; Heagerty, PJ; Buchbinder, R (Jul 12, 2011). "Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta-analysis". BMJ (Clinical Research Ed.). 343: d3952. doi:10.1136/bmj.d3952. PMC 3133975. PMID 21750078.
14. Itshayek, E; Miller, P; Barzilay, Y; Hasharoni, A; Kaplan, L; Fraifeld, S; Cohen, JE (June 2012). "Vertebral augmentation in the treatment of vertebral compression fractures: review and new insights from recent studies". Journal of Clinical Neuroscience. 19 (6): 786–91. doi:10.1016/j.jocn.2011.12.015. PMID 22595547. S2CID 8301676.
15. Kallmes DF, Comstock BA, Heagerty PJ, et al. (August 2009). "A randomized trial of vertebroplasty for osteoporotic spinal fractures". N. Engl. J. Med. 361 (6): 569–79. doi:10.1056/NEJMoa0900563. PMC 2930487. PMID 19657122.
16. Buchbinder R, Osborne RH, Ebeling PR, et al. (August 2009). "A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures". N. Engl. J. Med. 361 (6): 557–68. doi:10.1056/NEJMoa0900429. hdl:10536/DRO/DU:30019842. PMID 19657121.
17. ^ Zou, J; Mei, X; Zhu, X; Shi, Q; Yang, H (Jul–Aug 2012). "The long-term incidence of subsequent vertebral body fracture after vertebral augmentation therapy: a systemic review and meta-analysis". Pain Physician. 15 (4): E515–22. PMID 22828697.
18. Moan R. continues over value of vertebroplasty. Diagnostic Imaging. 2010;32(2) 5.
19. Jensen, ME; McGraw, JK; Cardella, JF; Hirsch, JA (July 2009). "Position statement on percutaneous vertebral augmentation: a consensus statement developed by the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, American Association of Neurological Surgeons/Congress of Neurological Surgeons, and American Society of Spine Radiology". Journal of Vascular and Interventional Radiology. 20 (7 Suppl): S326–31. doi:10.1016/j.jvir.2009.04.022. PMID 19560019.
20. Clark, William; Bird, Paul; Diamond, Terrance; Gonski, Peter; Gebski, Val (9 March 2019). "Cochrane vertebroplasty review misrepresented evidence for vertebroplasty with early intervention in severely affected patients". BMJ Evidence-Based Medicine. 25 (online first): bmjebm–2019–111171. doi:10.1136/bmjebm-2019-111171. PMC 7286037. PMID 30852489.
21. Esses, Stephen I.; et al. (September 2010), The Treatment of Symptomatic Osteoporotic Spinal Compression Fractures: Guideline and Evidence Report (PDF), American Academy of Orthopaedic Surgeons
22. ^ Review of interim funded service: Vertebroplasty and New review of Kyphoplasty (PDF). Medical Services Advisory Committee. April 2011. ISBN 9781742414560.
23. ^ Montagu, A; Speirs, A; Baldock, J; Corbett, J; Gosney, M (July 2012). "A review of vertebroplasty for osteoporotic and malignant vertebral compression fractures". Age and Ageing. 41 (4): 450–5. doi:10.1093/ageing/afs024. PMID 22417981.
24. "Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures". NICE The National Institute for Health and Care Excellence. April 2013. p. 3. Archived from the original on 2 April 2015. Retrieved 17 March 2015.
25. Bliemel, C; Oberkircher, L; Buecking, B; Timmesfeld, N; Ruchholtz, S; Krueger, A (April 2012). "Higher incidence of new vertebral fractures following percutaneous vertebroplasty and kyphoplasty--fact or fiction?". Acta Orthopaedica Belgica. 78 (2): 220–9. PMID 22696994.
26. ^ Wang, LJ; Yang, HL; Shi, YX; Jiang, WM; Chen, L (August 2012). "Pulmonary cement embolism associated with percutaneous vertebroplasty or kyphoplasty: a systematic review". Orthopaedic Surgery. 4 (3): 182–9. doi:10.1111/j.1757-7861.2012.00193.x. PMC 6583132. PMID 22927153.
27. Morrison, WB; Parker, L; Frangos, AJ; Carrino, JA (April 2007). "Vertebroplasty in the United States: guidance method and provider distribution, 2001-2003". Radiology. 243 (1): 166–70. doi:10.1148/radiol.2431060045. PMID 17392252.
28. ^ REDBERG, Rita (May 25, 2011). "Squandering Medicare's Money". New York Times. Retrieved 18 January 2013.
29. Mathis, John M.; Deramond, Hervé; Belkoff, Stephen M., eds. (2006) . Percutaneous Vertebroplasty and Kyphoplasty (2nd ed.). Springer Science+Business Media. pp. 3–5. ISBN 978-0-387-29078-2.
30. Mehio, AK; Lerner, JH; Engelhart, LM; Kozma, CM; Slaton, TL; Edwards, NC; Lawler, GJ (August 2011). "Comparative hospital economics and patient presentation: vertebroplasty and kyphoplasty for the treatment of vertebral compression fracture". AJNR. American Journal of Neuroradiology. 32 (7): 1290–4. doi:10.3174/ajnr.A2502. PMC 7966060. PMID 21546460.
31. Cloft, HJ; Jensen, ME (February 2007). "Kyphoplasty: an assessment of a new technology". AJNR. American Journal of Neuroradiology. 28 (2): 200–3. PMC 7977394. PMID 17296979.
32. Ong, KL; Lau, E; Kemner, JE; Kurtz, SM (April 2013). "Two-year cost comparison of vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: are initial surgical costs misleading?". Osteoporosis International. 24 (4): 1437–45. doi:10.1007/s00198-012-2100-0. PMID 22872070. S2CID 22020223.
33. Edidin, Avram; Ong, Kevin (2015), "Morbidity and Mortality After Vertebral Fractures: Comparison of Vertebral Augmentation and Nonoperative Management in the Medicare Population", Spine, 40 (15): 1228–41, doi:10.1097/BRS.0000000000000992, PMID 26020845, S2CID 20164158
34. Pinsker, Story by Joe. "The Covert World of People Trying to Edit Misplaced Pages—for Pay". The Atlantic. ISSN 1072-7825. Retrieved 2020-05-26.
35. Kolata, Gina (2019-01-24). "Spinal Fractures Can Be Terribly Painful. A Common Treatment Isn't Helping". The New York Times. ISSN 0362-4331. Retrieved 2020-05-26.

External links

• Spinal Fractures Can Be Terribly Painful. A Common Treatment Isn't Helping. NYTs 2019

• Orthopedic surgical procedures
• Bones of the vertebral column
• Interventional radiology